Literature DB >> 776581

Clinical and haemodynamic effects of minoxidil in refractory hypertension.

R Zacest, D B Frewin, M A Robinson, L L Wilson, J R Lawrence, A R Clarkson, B Jackson.   

Abstract

Thirteen patients whose hypertension had been resistant to conventional drug therapy, had minoxidil added to their regimen in doses from 5 to 60 mg/day. All responded with satisfactory reductions of blood pressure to mean values of 149/90mm Hg (supine) and 143/89mm Hg (standing). A significant portion of their previous antihypertensive therapy was either greatly decreased or withdrawn completely. Although fluid retention occurred in most patients as the dose of minoxidil was increased, this could be successfully checked by the use of diuretics. It was considered that in addition to beta-adrenoreceptor blocking drugs to control the reflexly induced cardiac stimulation, sufficiently aggressive diuretic therapy is mandatory to ensure the successful use of this drug. Haemodynamic evaluations in seven patients clearly showed that lowering of blood pressure was the result of decreases in peripheral vascular resistance as significant increases in the cardiac index occurred in all patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776581     DOI: 10.2165/00003495-197600111-00036

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

1.  Minoxidil in severe hypertension: value when conventional drugs have failed.

Authors:  J C Dormois; J L Young; A S Nies
Journal:  Am Heart J       Date:  1975-09       Impact factor: 4.749

2.  Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

Authors:  E Gilmore; J Weil; C Chidsey
Journal:  N Engl J Med       Date:  1970-03-05       Impact factor: 91.245

3.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

4.  Pharmacologic properties of minoxidil: a new hypotensive agent.

Authors:  D W DuCharme; W A Freyburger; B E Graham; R G Carlson
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

5.  A computer program to estimate cardiac output directly from dye-dilution curves.

Authors:  R C Hall; M J Tyler
Journal:  J Appl Physiol       Date:  1971-07       Impact factor: 3.531

6.  Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.

Authors:  R L Wilburn; A Blaufuss; C M Bennet
Journal:  Circulation       Date:  1975-10       Impact factor: 29.690

7.  Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilator.

Authors:  R Sannerstedt; L Brorson; G Berglund; L Werkö
Journal:  Acta Med Scand       Date:  1975-05
  7 in total
  4 in total

Review 1.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

2.  Antihypertensive effects of a novel peripheral vasodilator, Ro 12-4713.

Authors:  D Chu; G Cocco; C Strozzi; R Vallini; M Nonato; R Amrein
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

Review 3.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

4.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Authors:  Heiko M Mundt; Matthias Matenaer; Alexander Lammert; Uwe Göttmann; Bernhard K Krämer; Rainer Birck; Urs Benck
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.